Denosumab-associated jaw bone necrosis in cancer patients: retrospective descriptive case series study

BACKGROUND: Denosumab (DMB) is a bone antiresorptive agent used to treat osteoporosis or metastatic cancer of the bones. However, denosumab-associated osteonecrosis of the jaw (DRONJ) has become a common complication in cancer patients. The prevalence of osteonecrosis of the jaw (ONJ) in cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Ji-Yeon, Kim, Sang-Yup, Lim, Jae-Seok, Kim, Jwa-Young, Jin, Ga-Youn, Lee, Yeon-Jung, Lee, Eun-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313599/
https://www.ncbi.nlm.nih.gov/pubmed/37389685
http://dx.doi.org/10.1186/s40902-023-00391-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313599/
https://www.ncbi.nlm.nih.gov/pubmed/37389685
http://dx.doi.org/10.1186/s40902-023-00391-9

Ejemplares similares